Want to join the conversation?
Lab instruments provider $A's 2Q16 SG&A expense grew 9% versus 2Q15, due to wage increases, higher variable pay, impact of foreign currency movements and acquisition costs. Effective tax rate from continuing operations was 22.2% and income tax expense from continuing operations was $26MM in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?